TINEA AMIANTACEA

Benita Putri P

ABSTRACT
A condition which is : - Excessinve scalling of the scalp - Thick silvery-yellowish scales encircle the hair shaft - May bind down tuft of hair amiante is a french word for asbestos

INTRODUCTION

Tinea amiantacea also known as pityriasis amiantacea Present as tenaciously adherent surrounding base of scalp hairs that can result in hair loss In 1832 thus condition first described by Alibert as asbestos-like tinea

CASE REPORT

A 10 year old boy present with heavy scale onto hairs and separate and bind together their proximal portions

He was otherwise healty and did not take any medication. There were no other skin manifestations of psoriasis or seborrheic dermatitis. The patient was prescribed with grioseofulvin , the longest standing effective treatment for tinea capitis is griseofulvin given in a dose of 10mg/kg daily for a period of 6-8 weeks.

DISCUSSION
Tinea amiantacea or pityriasis amiantacea is a : Asbestos like thick scales attacched to the hair shaft The scales is an overlapping manner like flakes of asbestos Long standing inflammatory can cause permanent hair loss More common in female and younger age

The condition may be a reaction pattern to a number of inflammatory processes in scalp such as : Psoriasis Seborheic dermatitis Tinea capitis Atopic dermatitis etc

A recent report also describe PA as manifestationof darier disease The most common cause for PA is psoriasis and seborrheic dermatitis

Staphylococcus aureus has been documented to be present in the majority of patient with PA Like present as a secondary infection or normal colonization Responded well with : combined regimen of systemic topical antibiotic Topical corticosteroids

Our patient was prescribed with Griseofulvin 10 mg/kg daily for a period of 6-8 weeks Fungistatic in vitro Inhibition of the formation of intracellular microtubules

Effective timely treatment fo allopecia Keratolitic Topical corticosteroids Shampoo containing ketokonazole, ciclopirox and zinc

Reference 1. Plewing G, Jansen T. Seborrheic dermatitis. In Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick's dermatology in general medicine, 6th edition. New York: McGraw-Hill; 2003. 1200-1201 2. Alibert JL. La porrigine amiantacea. Monographie des Dermatoses. Paris, France, 1832: 293-5. 3. Knight AG. Pityriasis amiantacea: a clinical and histopathological investigation. Clin Exp Dermatol 1977; 2: 137-142. 4. Hansted B, Lindoskov R. Pityriasis amiantacea and psoriasis: a follow-up study. Dermatologica. 1983; 166: 314-315. 5. Ring DS, Kaplan D. Pityriasis amiantacea: a report of 10 cases. Arch Dermatol 1993; 129: 913-914. 6. Abdel-Hamid IA, Salah AA, Moustafa YM, El-Labban AM. Pityriasis amiantacea: a clinical and etiopathologic study of 85 patients. Int J Dermatol 2003; 42: 260-4. 7. Langtry JAA, Ive FA. Pityriasis amiantacea, an unrecognized cause of scarring alopecia, described in four patients. Acta Derm Venereol. 1991; 71: 352-353.

8. Ring DS, Kaplan D. Pityriasis amiantacea: a report of 10 cases. Arch Dermatol 1993; 129: 913-914. 9. Hussain W, I. Coulson H, Salman WD. Pityriasis Amiantacea as the sole manifestation of Darier's disease. Clinical and Experimental Dermatology 2009; 34:552-558. 10. Shalev RM, Cohen AD, Medvedovsky E, Sashavinsky S, Tchetov T, Vardy DA. Pityriasis amiantacea associated with Staphylococcus aureus superinfection in bedouin patients. Microbial Ecology in Health and Disease 2004; 16-4: 218-221. 11. van der Vleuten CJ, van de Kerkhof PC. Management of scalp psoriasis: guidelines for corticosteroid use in combination treatment. Drugs 2001; 61(11):1593-8. 12. Matsunaga J, Maibach HI, Epstein E. Scalp and Hair, Palms and Soles. In Roenigk HH, Maibach HI. Psoriasis. 3rd edition. New York: Marcel Dekker Inc., 1998. 45-57. 13. Warren RB, Brown BC, Griffiths CE. Topical treatments for scalp psoriasis. Drugs 2008; 68(16):2293-302. 14. Alexis AF, Strober BE. Off-label dermatologic uses of anti-TNF alpha therapies. J Cutan Med Surg 2005; 9(6):296-302. 15. Gupta AK, Skinner AR. A review of the use of infliximab to manage cutaneous dermatoses. J Cutan Med Surg 2004; 8:77-89.